thiophenes has been researched along with Meningitis, Meningococcal, Serogroup A in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braccini, T; Grandgirard, D; Koedel, U; Leib, SL; Oggioni, MR; Ricci, S; Salvatore, P; Wenzel, M | 1 |
| Frosch, M; Koedel, U; Lorenzl, S; Paul, R; Pfister, HW; Sporer, B; Vogel, U | 1 |
2 other study(ies) available for thiophenes and Meningitis, Meningococcal, Serogroup A
| Article | Year |
|---|---|
Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Cerebellum; Cerebral Hemorrhage; Chemokines; Cytokines; Dentate Gyrus; Disease Models, Animal; Female; Kaplan-Meier Estimate; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Meningitis, Meningococcal; Mice; Phenylalanine; Thiophenes | 2014 |
Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis.
Topics: Adult; Aged; Animals; Blood-Brain Barrier; Capillary Permeability; Cerebrospinal Fluid; Collagenases; Female; Humans; Intracranial Pressure; Leukocyte Count; Male; Matrix Metalloproteinase 9; Meningitis, Meningococcal; Metalloendopeptidases; Middle Aged; Phenylalanine; Rats; Rats, Wistar; Thiophenes; Tissue Inhibitor of Metalloproteinase-1 | 1998 |